X0609 4 2026-05-15 0 0001796209 APi Group Corp APG 0001093725 ASHKEN IAN G H false C/O API GROUP CORP 1100 OLD HIGHWAY 8 NW NEW BRIGHTON MN 55112 1 0 0 0 0 Common Stock 2026-05-16 4 M 0 4740 0 A 58470 I By Ian G.H. Ashken Living Trust Common Stock 15552 I By Mariposa Acquisition IV, LLC Common Stock 9477284 I by Nancy and Ian Ashken Investment Trust LLLP Common Stock 300000 I See footnote Restricted Stock Units 2026-05-15 4 A 0 4047 0 A Common Stock 4047 4047 D Restricted Stock Units 2026-05-16 4 M 0 4740 0 D Common Stock 4740 0 D Series A Preferred Stock Common Stock 1152000 1152000 I By Mariposa Acquisition IV, LLC On May 16, 2026, 4,740 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock. Following the vesting of the Reporting Person's restricted stock units, the Reporting Person transferred 4,740 shares of the Issuer's Common Stock to The Ian G.H. Ashken Living Trust, of which Mr. Ashken is the trustee and beneficiary, in an exempt transaction pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. The shares of Common Stock reported herein are held directly by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein. The shares of Common Stock and Series A Preferred Stock are held directly by Mariposa Acquisition IV, LLC. The Nancy and Ian Ashken Investment Trust LLLP (the "Ashken Investment Trust"), the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary, holds a limited liability company interest in Mariposa Acquisition IV, LLC and, as a result, may be deemed to have a pecuniary interest in 15,552 shares of Common Stock and 1,152,000 shares of Series A Preferred Stock held by Mariposa Acquisition IV, LLC. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein. The shares of Common Stock reported herein are held directly by the Ashken Investment Trust , the general partner of which is wholly-owned by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein. Held jointly in an account by the Ashken Trust and the Nancy K. Ashken Living Trust. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. These restricted stock units vest on May 15, 2027, which is the one-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. These restricted stock units vest on May 16, 2026, which is the one-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock on the last day of the seventh full financial year of the Issuer following October 1, 2019 (or if such date is not a trading day, the first trading day immediately following such date). /s/ Louis B. Lambert, Attorney-in-Fact 2026-05-19